Lee N H, Hu J, el-Fakahany E E
Department of Pharmacology and Toxicology, University of Maryland School of Pharmacy, Baltimore.
J Pharmacol Exp Ther. 1992 Jul;262(1):312-6.
Muscarinic acetylcholine receptors belong to a superfamily of G-protein coupled receptors and contain within their structure several conserved aspartate residues. These residues have been implicated to play important roles in the interaction of agonists and their competitive antagonists with the receptor. In the present work, we investigated whether the same residues might also serve as important contact points for allosteric antagonists of muscarinic receptors, because the majority of these compounds are cationic in nature, or if such residues are involved in modification of receptor conformation by these antagonists. Gallamine was used as a prototype for these antagonists. Site-directed mutagenesis of the m1 muscarinic receptor subtype was utilized to define some of the molecular determinants involved in cooperative allosteric interactions. We report that substitution of the aspartate residue at position 71, but not at positions 99 and 122 with asparagine, affected the affinity of gallamine for the unliganded m1 receptor. A similar substitution at positions 71 and 99 decreased the magnitude of its cooperative effects on the binding of [3H]N-methylscopolamine. Our data suggest that these residues are implicated in cooperative interactions. At present, however, we cannot discount a more pivotal role of other residues on the receptor sequence in allosteric interactions. The data also support the notion that different molecular entities are required for the binding of allosteric antagonists as compared to the interaction of agonists and competitive antagonists at the receptor.
毒蕈碱型乙酰胆碱受体属于G蛋白偶联受体超家族,其结构中含有几个保守的天冬氨酸残基。这些残基被认为在激动剂及其竞争性拮抗剂与受体的相互作用中起重要作用。在本研究中,我们调查了这些相同的残基是否也可能作为毒蕈碱受体变构拮抗剂的重要接触点,因为这些化合物大多数本质上是阳离子型的,或者这些残基是否参与了这些拮抗剂对受体构象的修饰。加拉明被用作这些拮抗剂的原型。利用m1毒蕈碱受体亚型的定点诱变来确定参与协同变构相互作用的一些分子决定因素。我们报告,将第71位的天冬氨酸残基替换为天冬酰胺,但第99位和第122位不进行替换,会影响加拉明对未结合配体的m1受体的亲和力。在第71位和第99位进行类似的替换会降低其对[3H]N-甲基东莨菪碱结合的协同效应的幅度。我们的数据表明这些残基参与了协同相互作用。然而,目前我们不能排除受体序列上其他残基在变构相互作用中发挥更关键作用的可能性。数据还支持这样一种观点,即与激动剂和竞争性拮抗剂在受体上的相互作用相比,变构拮抗剂的结合需要不同的分子实体。